Search - tctmd.com

Displaying 481 - 500 of 563

Sort: Relevancy | Date

News Conference News

ACCEL-BLEED: Mild Bleeding Correlated with Platelet Reactivity One Month Post PCI

November 22, 2011

News Conference News

Supervised Exercise Improves Walking Outcomes Better Than Stenting in PAD

November 16, 2011

News Conference News

No LateTIME Benefit for Cell Therapy After Primary PCI

November 14, 2011

News Conference News

Two New SES Show Improvement Over First-Generation Stents

Yael L. Maxwell

November 10, 2011

News Industry News

Tryton Announces Successful Live Case Transmission at TCT Conference in San Francisco

November 09, 2011

News Industry News

BIOTRONIK Announces Positive Results for Pantera Lux Paclitaxel Releasing Balloon

November 09, 2011

News Conference News

Complications After TAVR: Manageable, But Important to Consider

November 09, 2011

News Conference News

Safety, Efficacy Reported with FIREHAWK SES

November 08, 2011

News Industry News

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

November 08, 2011

News Conference News

Caution Urged in Widespread Adoption of TAVR

November 08, 2011

News Industry News

Cardiovascular Systems' Peripheral and Coronary Data From Six Studies Presented at TCT

November 08, 2011

News Conference News

C-Pulse Heart Assist Device Improved Ventricular Remodeling, HF Symptoms

November 07, 2011

News Industry News

Sunshine Heart Announces Results of Its C-Pulse(R) Feasibility Trial at the Transcatheter Cardiovascular Therapeutics Conference

November 06, 2011

News Conference News

No Change Seen in European TAVR Clinical Use Patterns

November 06, 2011

News Conference News

New Stem Cell Therapies Promising in Severe Heart Disease

November 06, 2011

News Conference News

Coming to Grips with CLOSURE I: PFO Device Plus Medical Therapy Not Superior to Medical Therapy Alone

November 06, 2011

News Industry News

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

November 04, 2011

News Industry News

FDA Approves XARELTO® (rivaroxaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

November 04, 2011

News Daily News

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

November 02, 2011

News Daily News

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

October 31, 2011

Advertisement

ACCEL-BLEED: Mild Bleeding Correlated with Platelet Reactivity One Month Post PCI

Supervised Exercise Improves Walking Outcomes Better Than Stenting in PAD

No LateTIME Benefit for Cell Therapy After Primary PCI

Two New SES Show Improvement Over First-Generation Stents

Tryton Announces Successful Live Case Transmission at TCT Conference in San Francisco

BIOTRONIK Announces Positive Results for Pantera Lux Paclitaxel Releasing Balloon

Complications After TAVR: Manageable, But Important to Consider

Safety, Efficacy Reported with FIREHAWK SES

Non-adherence to dual antiplatelet therapy following percutaneous coronary intervention results in higher rates of ischemic and bleeding events

Caution Urged in Widespread Adoption of TAVR

Cardiovascular Systems' Peripheral and Coronary Data From Six Studies Presented at TCT

C-Pulse Heart Assist Device Improved Ventricular Remodeling, HF Symptoms

Sunshine Heart Announces Results of Its C-Pulse(R) Feasibility Trial at the Transcatheter Cardiovascular Therapeutics Conference

No Change Seen in European TAVR Clinical Use Patterns

New Stem Cell Therapies Promising in Severe Heart Disease

Coming to Grips with CLOSURE I: PFO Device Plus Medical Therapy Not Superior to Medical Therapy Alone

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

FDA Approves XARELTO® (rivaroxaban) to Reduce the Risk of Stroke and Systemic Embolism in Patients with Nonvalvular Atrial Fibrillation

Thrombolysis with Immediate Transfer for PCI Safe for Rural STEMI Patients

First-Year Stent Thombosis Risk High—and Dangerous—in ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content